May 16, 2024Open Access

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Key Points

Key points are not available for this paper at this time.

Abstract

Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after radical prostatectomy is unclear.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Parker et al. (Thu,) studied this question.

synapsesocial.com/papers/68e69af9b6db643587620afc https://doi.org/https://doi.org/10.1016/s0140-6736(24)00548-8

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark

View Full Paper